Rvm Krishnamurthi, S. Mathai, AH Kim
Feb 1, 2009
Citations
0
Influential Citations
12
Citations
Quality indicators
Journal
British Journal of Pharmacology
Abstract
Background and purpose: Cyclo‐L‐glycyl‐L‐2‐allylproline (NNZ‐2591), a modified diketopiperazine, is neuroprotective and improves long‐term function after hypoxic‐ischaemic brain injury in rats. The present studies were designed to examine both the neuroprotective and neurotrophic actions of NNZ‐2591 on neurochemical and behavioural changes in a rat model of Parkinson's disease.